Condition
Eczema, Atopic clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Eczema, Atopic clinical trials that are recruiting, at sites in 15 countries (most in United States (3), Bulgaria (2), Canada (2)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 15Countries
Newest Eczema, Atopic clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Camoteskimab in adults with moderate-to-severe atopic dermatitis | Phase 2 | Birmingham, Alabama and 84 other locations | Recruiting | May 20, 2026 |
| Soquelitinib for adults with moderate to severe atopic dermatitis | Phase 2 | South San Francisco, California | Recruiting | Mar 2, 2026 |
| A medicine for eczema: see if PF-08049820 helps adults with moderate to severe atopic dermatitis | Phase 2 | Phoenix, Arizona and 51 other locations | Recruiting | Oct 14, 2025 |
| Testing a new hydrogel for treating mild to moderate eczema | Phase 2 | Brookvale, New South Wales and 11 other locations | Recruiting | Mar 4, 2025 |
| Cosmetic cream for treating very dry and irritated skin in children | — | Ciudad Autónoma de Buenos Aire, Ciudad Autónoma de Buenos Aire and 2 other locations | Recruiting | Oct 12, 2022 |
All recruiting trials (5)
-
Camoteskimab in adults with moderate-to-severe atopic dermatitis
This trial tests different doses of camoteskimab versus placebo to see if it helps adults with moderate-to-severe atopic dermatitis who have not fully responded to standard treatments.
-
Soquelitinib for adults with moderate to severe atopic dermatitis
This 12-week test gives adults with moderate to severe atopic dermatitis daily soquelitinib or a placebo to see if their skin and itch improve and to track side effects.
-
A medicine for eczema: see if PF-08049820 helps adults with moderate to severe atopic dermatitis
This study tests whether PF-08049820, taken as a daily pill, can safely help adults with moderate to severe eczema compared to a placebo.
-
Testing a new hydrogel for treating mild to moderate eczema
This study is testing a new hydrogel called zabalafin to see if it helps people with mild to moderate eczema feel better compared to a placebo.
-
Cosmetic cream for treating very dry and irritated skin in children
This study is testing a new cream for children with very dry and irritated skin to see if it helps improve their skin condition better than a fake cream.
Related topics
Quick answers
How many Eczema, Atopic clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (3 trials), Bulgaria (2 trials), Canada (2 trials), Czechia (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.